Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents-Reference-Cited by-同舟云学术

Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents

Published:2014-09 Issue:3 Volume:66 Page:459-465
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Pezaro Carmel J.,Omlin Aurelius G.,Altavilla Amelia,Lorente David,Ferraldeschi Roberta,Bianchini Diletta,Dearnaley David,Parker Christopher,de Bono Johann S.,Attard Gerhardt

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

2. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;De Bono;Lancet,2010

4. Abiraterone and increased survival in metastatic prostate cancer;De Bono;N Engl J Med,2011

5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06

2. Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer;Cell Death & Disease;2024-08-01

3. Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer;2024-04-29

4. Aptamers for the Delivery of Plant-Based Compounds: A Review;Pharmaceutics;2024-04-14

5. Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs;International Journal of Molecular Sciences;2023-09-03